{"id":124379,"date":"2024-05-17T13:38:48","date_gmt":"2024-05-17T08:08:48","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=124379"},"modified":"2024-05-17T14:03:07","modified_gmt":"2024-05-17T08:33:07","slug":"pharma-stock-jumps-3-2-after-company-enters-into-an-agreement-with-msn-laboratories-for-us-market","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-2-after-company-enters-into-an-agreement-with-msn-laboratories-for-us-market\/","title":{"rendered":"Pharma stock jumps 3.2% after company enters into an agreement with MSN Laboratories for US market"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2925276467\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Following the announcement of entering into a licensing and supply agreement with MSN Laboratories, the share price of this large-cap pharma stock and a global innovation-driven healthcare company surged by 3.2 percent on BSE to hit an intraday high at Rs. 1,041.1 during the Friday morning trading session.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3337188268\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>At 10:45 a.m., the shares of <strong>Zydus Lifesciences Limited<\/strong> were trading in the green at Rs. 1,033.2, up by 2.43 percent, with a market capitalisation of Rs. 1.03 lakh crore.&nbsp;<\/p><p><strong>According to the latest regulatory filings with the stock exchanges, Zydus Lifesciences Global FZE, a wholly-owned subsidiary of Zydus Lifesciences Ltd., entered into a licensing and supply agreement with MSN Laboratories for Cabozantinib Tablets for the US market.&nbsp;<\/strong><\/p><p>Cabozantinib Tablet, a generic version of CABOMETYX\u00ae, is used in the treatment of different types of cancer including liver cancer, kidney cancer, and thyroid cancer.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-639157926\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>Under the terms of the agreement, MSN Laboratories will manufacture and supply the generic version of CABOMETYX\u00ae after receiving the receipt of regulatory approval, while Zydus will market, distribute, and sell the Product exclusively in the US market.&nbsp;<\/p><p>MSN was the first sole ANDA applicant for Cabozantinib Tablets, to submit a substantially complete ANDA with a paragraph IV certification and therefore may be eligible for 180 days of generic drug exclusivity for the generic version of CABOMETYX\u00ae.&nbsp;<\/p><p>The total addressable market opportunity of Cabozantinib Tablets in the United States is estimated to be around Rs. 1.06 lakh crore, or $1,464 million.&nbsp;<\/p><p>Zydus Lifesciences reported a 4.5 percent YoY growth in revenue from operations from Rs. 4,160 crore in Q3 FY22-23 to Rs. 4,344 crore in Q3 FY23-24. During the same period, net profit increased by 25.3 percent from Rs. 585.3 crore to Rs. 733.5 crore.&nbsp;<\/p><p>Zydus Lifesciences Ltd. is one of the leading players in the Indian pharmaceutical market having a presence across key therapy areas. It is an innovative, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Shivani Singh<\/strong><\/p><\/blockquote><h4 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h4><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.<\/strong><\/p><div class=\"trade-content-10\" id=\"trade-263836189\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><div class=\"trade-after-content\" id=\"trade-4185221894\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Following the announcement of entering into a licensing and supply agreement with MSN Laboratories, the share price of this large-cap pharma stock and a global innovation-driven healthcare company surged by 3.2 percent on BSE to hit an intraday high at Rs. 1,041.1 during the Friday morning trading session.&nbsp; At 10:45 a.m., the shares of Zydus [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":98971,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,13525],"tags":[],"class_list":["post-124379","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-stock-updates"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps 3.2% after company enters into an agreement with MSN Laboratories for US market - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Following the announcement of entering into a licensing and supply agreement with MSN Laboratories, the share price of this large-cap pharma stock and a global innovation-driven healthcare company surged by 3.2 percent on BSE to hit an intraday high at Rs. 1,041.1 during the Friday morning trading session.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-2-after-company-enters-into-an-agreement-with-msn-laboratories-for-us-market\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps 3.2% after company enters into an agreement with MSN Laboratories for US market\" \/>\n<meta property=\"og:description\" content=\"Following the announcement of entering into a licensing and supply agreement with MSN Laboratories, the share price of this large-cap pharma stock and a global innovation-driven healthcare company surged by 3.2 percent on BSE to hit an intraday high at Rs. 1,041.1 during the Friday morning trading session.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-2-after-company-enters-into-an-agreement-with-msn-laboratories-for-us-market\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-17T08:08:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-17T08:33:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-2-after-company-enters-into-an-agreement-with-msn-laboratories-for-us-market\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-2-after-company-enters-into-an-agreement-with-msn-laboratories-for-us-market\/\",\"name\":\"Pharma stock jumps 3.2% after company enters into an agreement with MSN Laboratories for US market - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-2-after-company-enters-into-an-agreement-with-msn-laboratories-for-us-market\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-2-after-company-enters-into-an-agreement-with-msn-laboratories-for-us-market\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"datePublished\":\"2024-05-17T08:08:48+00:00\",\"dateModified\":\"2024-05-17T08:33:07+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Following the announcement of entering into a licensing and supply agreement with MSN Laboratories, the share price of this large-cap pharma stock and a global innovation-driven healthcare company surged by 3.2 percent on BSE to hit an intraday high at Rs. 1,041.1 during the Friday morning trading session.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-2-after-company-enters-into-an-agreement-with-msn-laboratories-for-us-market\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-2-after-company-enters-into-an-agreement-with-msn-laboratories-for-us-market\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-2-after-company-enters-into-an-agreement-with-msn-laboratories-for-us-market\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-2-after-company-enters-into-an-agreement-with-msn-laboratories-for-us-market\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps 3.2% after company enters into an agreement with MSN Laboratories for US market\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps 3.2% after company enters into an agreement with MSN Laboratories for US market - Trade Brains Features","description":"Following the announcement of entering into a licensing and supply agreement with MSN Laboratories, the share price of this large-cap pharma stock and a global innovation-driven healthcare company surged by 3.2 percent on BSE to hit an intraday high at Rs. 1,041.1 during the Friday morning trading session.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-2-after-company-enters-into-an-agreement-with-msn-laboratories-for-us-market\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps 3.2% after company enters into an agreement with MSN Laboratories for US market","og_description":"Following the announcement of entering into a licensing and supply agreement with MSN Laboratories, the share price of this large-cap pharma stock and a global innovation-driven healthcare company surged by 3.2 percent on BSE to hit an intraday high at Rs. 1,041.1 during the Friday morning trading session.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-2-after-company-enters-into-an-agreement-with-msn-laboratories-for-us-market\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-05-17T08:08:48+00:00","article_modified_time":"2024-05-17T08:33:07+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-2-after-company-enters-into-an-agreement-with-msn-laboratories-for-us-market\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-2-after-company-enters-into-an-agreement-with-msn-laboratories-for-us-market\/","name":"Pharma stock jumps 3.2% after company enters into an agreement with MSN Laboratories for US market - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-2-after-company-enters-into-an-agreement-with-msn-laboratories-for-us-market\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-2-after-company-enters-into-an-agreement-with-msn-laboratories-for-us-market\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","datePublished":"2024-05-17T08:08:48+00:00","dateModified":"2024-05-17T08:33:07+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Following the announcement of entering into a licensing and supply agreement with MSN Laboratories, the share price of this large-cap pharma stock and a global innovation-driven healthcare company surged by 3.2 percent on BSE to hit an intraday high at Rs. 1,041.1 during the Friday morning trading session.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-2-after-company-enters-into-an-agreement-with-msn-laboratories-for-us-market\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-2-after-company-enters-into-an-agreement-with-msn-laboratories-for-us-market\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-2-after-company-enters-into-an-agreement-with-msn-laboratories-for-us-market\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/04\/pharma-cover-image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-3-2-after-company-enters-into-an-agreement-with-msn-laboratories-for-us-market\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps 3.2% after company enters into an agreement with MSN Laboratories for US market"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/124379","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=124379"}],"version-history":[{"count":2,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/124379\/revisions"}],"predecessor-version":[{"id":124383,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/124379\/revisions\/124383"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/98971"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=124379"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=124379"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=124379"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}